FULMAPA Trademark
Trademark Overview
On Tuesday, May 8, 2018, a trademark application was filed for FULMAPA with the United States Patent and Trademark Office. The USPTO has given the FULMAPA trademark a serial number of 79233936. The federal status of this trademark filing is REGISTERED as of Tuesday, December 4, 2018. This trademark is owned by Novartis AG. The FULMAPA trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
General Information
| Serial Number | 79233936 |
| Word Mark | FULMAPA |
| Filing Date | Tuesday, May 8, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 4, 2018 |
| Registration Number | 5619795 |
| Registration Date | Tuesday, December 4, 2018 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 18, 2018 |
Trademark Statements
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 12, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Friday, March 1, 2019 | NOTIFICATION PROCESSED BY IB |
| Wednesday, January 16, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, January 16, 2019 | FINAL DISPOSITION PROCESSED |
| Thursday, January 3, 2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Tuesday, December 4, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Friday, November 2, 2018 | NOTIFICATION PROCESSED BY IB |
| Tuesday, September 18, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 5, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 5, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 29, 2018 | NOTICE OF PUBLICATION |
| Thursday, July 5, 2018 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, July 4, 2018 | NOTICE OF PUBLICATION |
| Tuesday, June 19, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 19, 2018 | ASSIGNED TO EXAMINER |
| Saturday, June 16, 2018 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 12, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, June 11, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, June 7, 2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
